However, as a downstream adaptor protein of RIG-I, recent studies have demonstrated that MAVS influences dendritic cells (DCs) by inhibiting the production of IL-12, thereby impairing the functional efficacy of CD8+ T cells and facilitating tumor cell escape 17. Here, RIGI is linked to neoplasm.